VASO
Vaso Corporation
Price Chart
Latest Quote
$0.20
+0.00 (+0.00%)
Current Price
| Previous Close | $0.20 |
| Open | $0.20 |
| Day High | $0.20 |
| Day Low | $0.19 |
| Volume | 47,777 |
Stock Information
| Shares Outstanding | 176.00M |
| Total Debt | $1.81M |
| Cash Equivalents | $35.05M |
| Revenue | $88.99M |
| Net Income | $1.76M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $35.20M |
| P/E Ratio | 20.00 |
| EPS (TTM) | $0.01 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.46M |
| Sales | $88.99M |
| Income | $1.76M |
| Book/sh | $0.17 |
| Cash/sh | $0.20 |
| Employees | 282 |
Financial Ratios
| Debt/Eq | 6.15 |
Returns & Margins
| Gross Margin | 61.68% |
| Operating Margin | -6.87% |
| Profit Margin | 1.97% |
Ownership
| Insider Ownership | 43.84% |
| Institutional Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.40 |
| P/B | 1.20 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.21 |
| SMA50 | $0.19 |
| SMA200 | $0.16 |
| RSI | 52.94 |
| ATR | 0.0214 |
| Shares Float | 98.80M |
| Volatility | 0.53 |
| Rel Volume | 0.22 |
Performance History
| Week | -4.76% |
| Month | +5.26% |
| Quarter | +17.65% |
| 6 Months | +25.00% |
| YTD | +17.65% |
| Year | +53.85% |
| 3 Years | -9.09% |
| 5 Years | +233.33% |
| 10 Years | +25.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.20 | 47,777 |
| 2026-06-03 | $0.20 | 36,800 |
| 2026-06-02 | $0.20 | 148,000 |
| 2026-06-01 | $0.22 | 23,200 |
| 2026-05-29 | $0.21 | 79,500 |
| 2026-05-28 | $0.21 | 76,400 |
| 2026-05-27 | $0.22 | 229,200 |
| 2026-05-26 | $0.23 | 90,600 |
| 2026-05-22 | $0.23 | 11,100 |
| 2026-05-21 | $0.21 | 15,300 |
| 2026-05-20 | $0.23 | 236,700 |
| 2026-05-19 | $0.23 | 402,500 |
| 2026-05-18 | $0.25 | 495,500 |
| 2026-05-15 | $0.23 | 1,375,300 |
| 2026-05-14 | $0.19 | 62,500 |
| 2026-05-13 | $0.19 | 81,800 |
| 2026-05-12 | $0.20 | 139,600 |
| 2026-05-11 | $0.20 | 652,200 |
| 2026-05-08 | $0.18 | 39,900 |
| 2026-05-07 | $0.18 | 42,000 |
| 2026-05-06 | $0.19 | 54,200 |
| 2026-05-05 | $0.19 | 117,500 |
| 2026-05-04 | $0.18 | 66,900 |
About Vaso Corporation
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed network infrastructure, such as routers, switches, and other core equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
đ° Latest News
Vaso Stock Gains Post Q1 Earnings, Deferred Revenue Grows
Zacks âĸ 2026-05-21T16:47:00Z
The Zacks Analyst Blog Highlights Caterpillar, Texas Instruments, Boeing, Kewaunee Scientific and Vaso
Zacks âĸ 2026-04-27T12:54:00Z
Top Stock Reports for Caterpillar, Texas Instruments & Boeing
Zacks âĸ 2026-04-24T20:41:00Z
Vaso Stock Declines Post Q4 Earnings Despite Revenue Growth
Zacks âĸ 2026-04-02T16:23:00Z
The Zacks Analyst Blog Highlights Eli Lilly, Shell, ICICI Bank, Frequency Electronics and Vaso
Zacks âĸ 2025-12-23T15:27:00Z
Top Analyst Reports for Eli Lilly, Shell & ICICI Bank
Zacks âĸ 2025-12-22T22:14:00Z
How Indonesiaâs SIHREN CT Deal And New Financing At GEHC Have Changed Its Investment Story
Simply Wall St. âĸ 2025-12-18T00:14:57Z
Nanox to acquire VHC IT to accelerate AI deployment in US
Hospital Management âĸ 2025-11-20T10:11:30Z
Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround
Zacks âĸ 2025-11-19T16:36:00Z
The Zacks Analyst Blog Highlights Roche, Linde, Disney and Vaso
Zacks âĸ 2025-09-16T08:59:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $34,717,000 | $30,431,000 | $31,392,000 | $32,446,000 |
| Cost Of Revenue | $34,717,000 | $30,431,000 | $31,392,000 | $32,446,000 |
| Total Revenue | $86,767,000 | $81,024,000 | $79,294,000 | $75,579,000 |
| Operating Revenue | $86,767,000 | $81,024,000 | $79,294,000 | $75,579,000 |
| Expenses | ||||
| Interest Expense | $4,000 | $50,000 | $44,000 | $312,000 |
| Total Expenses | $84,552,000 | $76,264,000 | $72,840,000 | $72,760,000 |
| Other Income Expense | $-1,934,000 | $-569,000 | $-2,000 | $3,646,000 |
| Net Non Operating Interest Income Expense | $996,000 | $714,000 | $99,000 | $-214,000 |
| Interest Expense Non Operating | $4,000 | $50,000 | $44,000 | $312,000 |
| Operating Expense | $49,835,000 | $45,833,000 | $41,448,000 | $40,314,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Net Interest Income | $996,000 | $714,000 | $99,000 | $-214,000 |
| Interest Income | $1,000,000 | $764,000 | $143,000 | $98,000 |
| Normalized Income | $2,391,250 | $5,362,392 | $11,295,580 | $2,542,233 |
| Net Income From Continuing And Discontinued Operation | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Total Operating Income As Reported | $285,000 | $4,195,000 | $6,454,000 | $2,819,000 |
| Net Income Common Stockholders | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Net Income | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Net Income Including Noncontrolling Interests | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Net Income Continuous Operations | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Pretax Income | $1,277,000 | $4,905,000 | $6,551,000 | $6,251,000 |
| Special Income Charges | $-1,934,000 | $-569,000 | $-2,000 | $3,646,000 |
| Interest Income Non Operating | $1,000,000 | $764,000 | $143,000 | $98,000 |
| Operating Income | $2,215,000 | $4,760,000 | $6,454,000 | $2,819,000 |
| Gross Profit | $52,050,000 | $50,593,000 | $47,902,000 | $43,133,000 |
| Per Share | ||||
| Diluted EPS | $0.01 | $0.03 | $0.06 | $0.04 |
| Basic EPS | $0.01 | $0.03 | $0.07 | $0.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $-493,750 | $-11,608 | $-420 | $88,233 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $4,039,000 | $6,523,000 | $8,520,000 | $6,757,000 |
| Total Unusual Items | $-1,934,000 | $-569,000 | $-2,000 | $3,646,000 |
| Total Unusual Items Excluding Goodwill | $-1,934,000 | $-569,000 | $-2,000 | $3,646,000 |
| Reconciled Depreciation | $824,000 | $999,000 | $1,923,000 | $3,840,000 |
| EBITDA (Bullshit earnings) | $2,105,000 | $5,954,000 | $8,518,000 | $10,403,000 |
| EBIT | $1,281,000 | $4,955,000 | $6,595,000 | $6,563,000 |
| Diluted Average Shares | $175,594,000 | $175,541,000 | $174,656,000 | $173,771,000 |
| Basic Average Shares | $175,395,000 | $174,441,000 | $173,065,000 | $171,688,000 |
| Diluted NI Availto Com Stockholders | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Tax Provision | $326,000 | $100,000 | $-4,743,000 | $151,000 |
| Gain On Sale Of Ppe | $-4,000 | $-4,000 | $-2,000 | $0 |
| Restructuring And Mergern Acquisition | $1,930,000 | $565,000 | - | - |
| Research And Development | $851,000 | $755,000 | $605,000 | $1,721,000 |
| Selling General And Administration | $48,984,000 | $45,078,000 | $40,843,000 | $38,593,000 |
| Gain On Sale Of Business | - | - | - | $0 |
| Other Special Charges | - | - | - | $-3,646,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $10,536,000 | $9,849,000 | $4,942,000 | $-6,453,000 |
| Total Assets | $82,938,000 | $75,757,000 | $71,645,000 | $52,361,000 |
| Total Non Current Assets | $31,753,000 | $30,658,000 | $30,655,000 | $24,558,000 |
| Other Non Current Assets | $58,000 | $60,000 | $70,000 | $60,000 |
| Non Current Deferred Assets | $8,943,000 | $8,777,000 | $8,871,000 | $2,237,000 |
| Non Current Deferred Taxes Assets | $4,904,000 | $4,956,000 | $5,007,000 | $219,000 |
| Non Current Accounts Receivable | $1,261,000 | $1,021,000 | $792,000 | $368,000 |
| Goodwill And Other Intangible Assets | $17,166,000 | $16,994,000 | $17,125,000 | $17,763,000 |
| Other Intangible Assets | $1,615,000 | $1,406,000 | $1,511,000 | $2,041,000 |
| Current Assets | $51,185,000 | $45,099,000 | $40,990,000 | $27,803,000 |
| Other Current Assets | $2,402,000 | $1,717,000 | $1,008,000 | $994,000 |
| Current Deferred Assets | $3,659,000 | $3,285,000 | $3,249,000 | $3,549,000 |
| Inventory | $911,000 | $1,470,000 | $1,473,000 | $1,147,000 |
| Receivables | $17,942,000 | $13,306,000 | $14,935,000 | $15,459,000 |
| Accounts Receivable | $16,999,000 | $12,377,000 | $14,514,000 | $21,197,000 |
| Allowance For Doubtful Accounts Receivable | $-10,708,000 | $-9,708,000 | $-6,947,000 | - |
| Gross Accounts Receivable | $27,707,000 | $22,085,000 | $21,461,000 | - |
| Cash Cash Equivalents And Short Term Investments | $26,271,000 | $25,321,000 | $20,325,000 | $6,654,000 |
| Cash And Cash Equivalents | $26,271,000 | $11,342,000 | $11,821,000 | $6,025,000 |
| Receivables Adjustments Allowances | - | - | $-6,947,000 | $-5,804,000 |
| Prepaid Assets | - | - | - | $994,000 |
| Debt | ||||
| Total Debt | $2,375,000 | $2,060,000 | $1,810,000 | $1,385,000 |
| Long Term Debt And Capital Lease Obligation | $1,278,000 | $1,051,000 | $934,000 | $593,000 |
| Current Debt And Capital Lease Obligation | $1,097,000 | $1,009,000 | $876,000 | $792,000 |
| Current Debt | $6,000 | $9,000 | $9,000 | $8,000 |
| Other Current Borrowings | $6,000 | $9,000 | $9,000 | $8,000 |
| Long Term Debt | - | $6,000 | $15,000 | $23,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $55,236,000 | $48,914,000 | $49,578,000 | $41,051,000 |
| Total Non Current Liabilities Net Minority Interest | $20,516,000 | $18,874,000 | $18,072,000 | $10,051,000 |
| Other Non Current Liabilities | $1,416,000 | $1,506,000 | $1,474,000 | $988,000 |
| Non Current Deferred Liabilities | $17,822,000 | $16,317,000 | $15,664,000 | $8,470,000 |
| Current Liabilities | $34,720,000 | $30,040,000 | $31,506,000 | $31,000,000 |
| Other Current Liabilities | $2,177,000 | $2,741,000 | $4,227,000 | $3,293,000 |
| Current Deferred Liabilities | $17,072,000 | $15,883,000 | $15,139,000 | $16,495,000 |
| Payables And Accrued Expenses | $11,233,000 | $7,925,000 | $8,612,000 | $8,023,000 |
| Payables | $5,044,000 | $3,372,000 | $3,082,000 | $3,519,000 |
| Total Tax Payable | $862,000 | $699,000 | $809,000 | $719,000 |
| Income Tax Payable | $60,000 | $0 | - | - |
| Accounts Payable | $4,179,000 | $2,670,000 | $2,270,000 | $2,797,000 |
| Equity | ||||
| Common Stock Equity | $27,702,000 | $26,843,000 | $22,067,000 | $11,310,000 |
| Total Equity Gross Minority Interest | $27,702,000 | $26,843,000 | $22,067,000 | $11,310,000 |
| Stockholders Equity | $27,702,000 | $26,843,000 | $22,067,000 | $11,310,000 |
| Gains Losses Not Affecting Retained Earnings | $-442,000 | $-304,000 | $-233,000 | $110,000 |
| Other Equity Adjustments | $-442,000 | $-304,000 | $-233,000 | $110,000 |
| Retained Earnings | $-34,081,000 | $-35,032,000 | $-39,837,000 | $-50,902,000 |
| Long Term Equity Investment | $436,000 | $683,000 | $889,000 | $1,043,000 |
| Other | ||||
| Ordinary Shares Number | $175,696,311 | $175,319,296 | $175,127,878 | $175,127,878 |
| Share Issued | $175,696,311 | $185,627,383 | $185,435,965 | $185,435,965 |
| Tangible Book Value | $10,536,000 | $9,849,000 | $4,942,000 | $-6,453,000 |
| Invested Capital | $27,708,000 | $26,858,000 | $22,091,000 | $11,341,000 |
| Working Capital | $16,465,000 | $15,059,000 | $9,484,000 | $-3,197,000 |
| Capital Lease Obligations | $2,369,000 | $2,045,000 | $1,786,000 | $1,354,000 |
| Total Capitalization | $27,702,000 | $26,849,000 | $22,082,000 | $11,333,000 |
| Treasury Stock | $0 | $2,000,000 | $2,000,000 | $2,000,000 |
| Additional Paid In Capital | $62,049,000 | $63,993,000 | $63,952,000 | $63,917,000 |
| Capital Stock | $176,000 | $186,000 | $185,000 | $185,000 |
| Common Stock | $176,000 | $186,000 | $185,000 | $185,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $17,822,000 | $16,317,000 | $15,664,000 | $8,470,000 |
| Long Term Capital Lease Obligation | $1,278,000 | $1,045,000 | $919,000 | $570,000 |
| Current Deferred Revenue | $17,072,000 | $15,883,000 | $15,139,000 | $16,495,000 |
| Current Capital Lease Obligation | $1,091,000 | $1,000,000 | $867,000 | $784,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,141,000 | $2,482,000 | $2,652,000 | $2,397,000 |
| Current Accrued Expenses | $6,189,000 | $4,553,000 | $5,530,000 | $4,504,000 |
| Dueto Related Parties Current | $3,000 | $3,000 | $3,000 | $3,000 |
| Investments And Advances | $436,000 | $683,000 | $889,000 | $1,043,000 |
| Goodwill | $15,551,000 | $15,588,000 | $15,614,000 | $15,722,000 |
| Net PPE | $3,889,000 | $3,123,000 | $2,908,000 | $3,087,000 |
| Accumulated Depreciation | $-10,712,000 | $-10,358,000 | $-9,787,000 | $-10,512,000 |
| Gross PPE | $14,601,000 | $13,481,000 | $12,695,000 | $13,599,000 |
| Other Properties | $11,913,000 | $11,298,000 | $10,668,000 | $11,560,000 |
| Machinery Furniture Equipment | $2,688,000 | $2,183,000 | $2,027,000 | $2,039,000 |
| Finished Goods | $303,000 | $627,000 | $716,000 | $399,000 |
| Work In Process | $12,000 | $11,000 | $6,000 | $4,000 |
| Raw Materials | $596,000 | $832,000 | $751,000 | $744,000 |
| Duefrom Related Parties Current | $943,000 | $929,000 | $421,000 | $66,000 |
| Other Short Term Investments | $0 | $13,979,000 | $8,504,000 | $629,000 |
| Treasury Shares Number | - | $10,308,087 | $10,308,087 | $10,308,087 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,828,000 | $4,565,000 | $13,850,000 | $7,400,000 |
| Operating Activities | ||||
| Operating Cash Flow | $3,281,000 | $5,296,000 | $14,416,000 | $7,815,000 |
| Cash Flow From Continuing Operating Activities | $3,281,000 | $5,296,000 | $14,416,000 | $7,815,000 |
| Operating Gains Losses | $247,000 | $206,000 | $154,000 | $-3,573,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,453,000 | $-731,000 | $-566,000 | $-415,000 |
| Investing Cash Flow | $11,730,000 | $-5,657,000 | $-8,417,000 | $-260,000 |
| Cash Flow From Continuing Investing Activities | $11,730,000 | $-5,657,000 | $-8,417,000 | $-260,000 |
| Net Other Investing Changes | $-573,000 | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $-89,000 | $-134,000 | $-230,000 | $-8,329,000 |
| Cash Flow From Continuing Financing Activities | $-89,000 | $-134,000 | $-230,000 | $-8,329,000 |
| Net Other Financing Charges | $-8,000 | $-6,000 | - | - |
| Other | ||||
| Repayment Of Debt | $-81,000 | $-128,000 | $-230,000 | $-8,329,000 |
| Interest Paid Supplemental Data | $4,000 | $17,000 | $44,000 | $347,000 |
| Income Tax Paid Supplemental Data | $183,000 | $89,000 | $48,000 | $113,000 |
| End Cash Position | $26,271,000 | $11,342,000 | $11,821,000 | $6,025,000 |
| Beginning Cash Position | $11,342,000 | $11,821,000 | $6,025,000 | $6,819,000 |
| Effect Of Exchange Rate Changes | $7,000 | $16,000 | $27,000 | $-20,000 |
| Changes In Cash | $14,922,000 | $-495,000 | $5,769,000 | $-774,000 |
| Net Issuance Payments Of Debt | $-81,000 | $-128,000 | $-230,000 | $-8,329,000 |
| Net Long Term Debt Issuance | $-81,000 | $-128,000 | $-230,000 | $-2,881,000 |
| Long Term Debt Payments | $-81,000 | $-128,000 | $-230,000 | $-2,881,000 |
| Net Investment Purchase And Sale | $13,756,000 | $-4,926,000 | $-7,851,000 | $155,000 |
| Sale Of Investment | $13,756,000 | $19,547,000 | $149,000 | $155,000 |
| Purchase Of Investment | $0 | $-24,473,000 | $-8,000,000 | $0 |
| Net PPE Purchase And Sale | $-1,453,000 | $-731,000 | $-566,000 | $-415,000 |
| Purchase Of PPE | $-1,453,000 | $-731,000 | $-566,000 | $-415,000 |
| Change In Working Capital | $-196,000 | $-879,000 | $5,735,000 | $532,000 |
| Change In Other Working Capital | $2,321,000 | $1,361,000 | $6,138,000 | $6,065,000 |
| Change In Other Current Liabilities | $-89,000 | $32,000 | $486,000 | $78,000 |
| Change In Other Current Assets | $-524,000 | $-213,000 | $-2,422,000 | $-212,000 |
| Change In Payables And Accrued Expense | $3,426,000 | $-2,330,000 | $1,915,000 | $238,000 |
| Change In Accrued Expense | $1,753,000 | $-2,617,000 | $2,342,000 | $3,869,000 |
| Change In Payable | $1,673,000 | $287,000 | $-427,000 | $-3,631,000 |
| Change In Account Payable | $1,511,000 | $402,000 | $-521,000 | $-3,492,000 |
| Change In Tax Payable | $162,000 | $-105,000 | $108,000 | $94,000 |
| Change In Income Tax Payable | $162,000 | $-105,000 | $108,000 | $94,000 |
| Change In Prepaid Assets | $-474,000 | $-1,271,000 | $-103,000 | $162,000 |
| Change In Inventory | $574,000 | $-22,000 | $-416,000 | $299,000 |
| Change In Receivables | $-5,430,000 | $1,564,000 | $137,000 | $-6,098,000 |
| Changes In Account Receivables | $-5,065,000 | $2,062,000 | $480,000 | $-6,052,000 |
| Stock Based Compensation | $54,000 | $48,000 | $35,000 | $31,000 |
| Provisionand Write Offof Assets | $777,000 | $66,000 | $63,000 | $448,000 |
| Asset Impairment Charge | $573,000 | $0 | $0 | $385,000 |
| Deferred Tax | $51,000 | $51,000 | $-4,788,000 | $52,000 |
| Deferred Income Tax | $51,000 | $51,000 | $-4,788,000 | $52,000 |
| Depreciation Amortization Depletion | $824,000 | $999,000 | $1,923,000 | $3,840,000 |
| Depreciation And Amortization | $824,000 | $999,000 | $1,923,000 | $3,840,000 |
| Earnings Losses From Equity Investments | $247,000 | $206,000 | $154,000 | $73,000 |
| Net Income From Continuing Operations | $951,000 | $4,805,000 | $11,294,000 | $6,100,000 |
| Net Short Term Debt Issuance | - | - | $0 | $-5,448,000 |
| Short Term Debt Payments | - | - | $0 | $-5,448,000 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
| Gain Loss On Sale Of Business | - | - | - | $0 |
Fetched: 2026-02-02